Constance, Germany

Antje Brueck-Scheffler



Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Antje Brueck-Scheffler: Innovator in Pharmaceutical Solutions

Introduction: Antje Brueck-Scheffler, based in Constance, Germany, is a notable inventor with a focus on advancing pharmaceutical compositions. With one registered patent to her name, she has contributed significantly to the field of respiratory treatment through her innovative methods.

Latest Patents: Antje's patent, titled "Aqueous suspensions of ciclesonide for nebulisation," relates to a method for preparing sterile aqueous suspensions of ciclesonide by sterilization using moist heat. This invention has important implications in the development of pharmaceutical compositions, particularly those designed for administration via nebulization aimed at the prophylaxis and treatment of respiratory diseases.

Career Highlights: Currently, Antje Brueck-Scheffler works at Covis Pharma GmbH, where her expertise in pharmaceutical innovations has been pivotal to the company's development efforts. Her commitment to improving patient outcomes through effective treatment options reflects her dedication to the healthcare industry.

Collaborations: While specific collaborations have not been detailed, Antje’s work at Covis Pharma GmbH positions her within a network of professionals focused on advancing pharmaceutical technologies. Through her contributions, she likely engages with various stakeholders in the medical and research communities to promote innovation.

Conclusion: Antje Brueck-Scheffler exemplifies the spirit of innovation in the pharmaceutical field. Her patent on ciclesonide suspensions demonstrates her ability to address critical healthcare challenges. As she continues her work, Antje promises to make further significant contributions to the treatment of respiratory diseases, solidifying her role as an important inventor in her field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…